Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.48 |
| ▸ | PHGDH | O43175 | 1/20 | 0.48 |
| ▸ | MGLL | Q99685 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dioxane SCHEMBL28081450 | 0.88 | POLB (0.46) | POLBKMT2AKDM4EFAAHPHGDH | |
| SCHEMBL17868921 | 0.87 | FASN (0.49) | POLBKDM4EEGFRERBB2SMN1; SMN2 | |
| SCHEMBL6108866 | 0.82 | SMN1; SMN2 (0.50) | POLBKMT2ALMNAL3MBTL1MEN1 | |
| SCHEMBL5580331 | 0.82 | POLB (0.52) | POLBKMT2AKDM4EFAAHPHGDH | |
| SCHEMBL17704773 | 0.80 | KMT2A (0.53) | POLBKMT2AKDM4EFAAHPHGDH | |
| SCHEMBL455438 | 0.80 | KMT2A (0.53) | POLBKMT2AKDM4EFAAHPHGDH | |
| SCHEMBL310005 | 0.80 | NPSR1 (0.64) | POLBKMT2AL3MBTL1NPSR1HTT | |
| SCHEMBL320116 | 0.80 | POLB (0.59) | POLBKMT2AKDM4EFAAHPHGDH | |
| SCHEMBL8986913 | 0.79 | ALDH1A1 (0.48) | POLBKMT2AKDM4ECA12CA1 | |
| SCHEMBL11616779 | 0.79 | ALDH1A1 (0.50) | KMT2AKDM4ELMNAHTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 862 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106884-A1 | PROCESS FOR PREPARING IMMUNOGENIC AZALIDES | ZOETIS SERVICES LLC (US) | 2026-05-21 | — | — | WO | claimed |
| CN-118754828-A | Solid phosgenation method preparation process method of No. II medium fixative | 西安近代化学研究所 | 2024-10-11 | — | — | CN | claimed |
| CN-112079965-A | Ultraviolet light rapid forming environment-friendly material for manufacturing 3D toys | 广东乐的互动娱乐股份有限公司 | 2020-12-15 | — | — | CN | claimed |
| CN-102659636-B | Alkali-free production technology of centralite II | Chongqing changfeng chemical industry co ltd | 2014-03-05 | — | — | CN | claimed |
| CN-102659636-A | Alkali-free production technology of centralite II | Chongqing changfeng chemical industry co ltd | 2012-09-12 | — | — | CN | claimed |
| CN-101066937-A | Synthesis process of N-chloromethyl-N-phenyl amino formyl chloride | JIANG YIQING (CN) | 2007-11-07 | — | — | CN | claimed |
| WO-2026106884-A1 | PROCESS FOR PREPARING IMMUNOGENIC AZALIDES | ZOETIS SERVICES LLC (US) | 2026-05-21 | — | — | WO | disclosed |
| EP-4737392-A1 | METHOD FOR PRODUCING CARBONYL HALIDE | National University Corporation Kobe University (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-20260102501-A1 | ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS | NUVATION BIO INC (US) | 2026-04-16 | — | — | US | disclosed |
| EP-4673149-A1 | NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA | Trustlife Global Inc. (US) | 2026-01-07 | — | — | EP | disclosed |
| EP-4665719-A1 | SMALL MOLECULE TREATMENT OF FATTY LIVER DISEASE AND HCC | ScandiEdge Therapeutics AB (SE) | 2025-12-24 | — | — | EP | disclosed |
| WO-2025229046-A1 | SUBSTITUTED HYDROQUINOLINES FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME | MOLIUS SAGLIK TEKNOLOJILERI ANONIM SIRKETI (TR) | 2025-11-06 | — | — | WO | disclosed |
| EP-4644375-A1 | SUBSTITUTED HYDROQUINOLINES FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME | Molius Saglik Teknolojileri Anonim Sirketi (TR) | 2025-11-05 | — | — | EP | disclosed |
| US-4053298-A | HERBICIDAL COMPOSITIONS CONTAINING 1-THIADIAZOLYL-6-CARBAMOYLOXYTETRAHYDROPYRIMIDINONES AND METHODS THEREFOR | VELSICOL CHEMICAL CORPORATION (US) | 1977-10-11 | — | — | US | disclosed |
| US-4046909-A | Pyrrolidylidene, piperidylidene and hexahydroazepinylidene ureas as CNS depressants | MCNEIL LABORATORIES, INCORPORATED (US) | 1977-09-06 | — | — | US | disclosed |
| US-4023957-A | Herbicidal 1-thiadiazolyl-5-carbamoyloxyimidazolidinones | VELSICOL CHEMICAL CORPORATION (US) | 1977-05-17 | — | — | US | disclosed |
| US-3998958-A | Pyrrolidylidene, piperidylidene and hexahydroazepinylidene ureas as CNS depressants | MCNEIL LABORATORIES, INCORPORATED (US) | 1976-12-21 | — | — | US | disclosed |
| US-3989710-A | POSTEMERGENCE HERBICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-02 | — | — | US | disclosed |
| US-3986973-A | CYANOFORMATES AND CYANOFORMAMIDES AS BLEACH ACTIVATORS | AMERICAN CYANAMID COMPANY (US) | 1976-10-19 | — | — | US | disclosed |
| US-3951976-A | 1-Thiadiazoly-6-carbamoyloxytetrahydropyrimidinones | VELSICOL CHEMICAL CORPORATION (US) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102501-A1 | ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS | NR5A1, NR5A2, NR3C1 | POLB 512/4885KMT2A 2820/4885KDM4E 3467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.